Abstract:BACKGROUND: An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically ill patients with SARS-CoV-2 infection is scarce. We aimed to describe the clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia.METHODS: In this single-centered, retrospective, observational study, we enrolled 52 critically ill adult patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) of Wuhan Jin Yin-tan hospital (Wuhan, China) between late December, 2019, and Jan 26, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were all collected. Data were compared between survivors and non-survivors. The primary outcome was 28-day mortality, as of Feb 9, 2020. Secondary outcomes included incidence of SARS-CoV-2-related acute respiratory distress syndrome (ARDS) and the proportion of patients requiring mechanical ventilation.FINDINGS: Of 710 patients with SARS-CoV-2 pneumonia, 52 critically ill adult patients were included. The mean age of the 52 patients was 59·7 (SD 13·3) years, 35 (67%) were men, 21 (40%) had chronic illness, 51 (98%) had fever. 32 (61·5%) patients had died at 28 days, and the median duration from admission to the intensive care unit (ICU) to death was 7 (IQR 3-11) days for non-survivors. Compared with survivors, non-survivors were older (64·6 years [11·2] vs 51·9 years [12·9]), more likely to develop ARDS (26 [81%] patients vs 9 [45%] patients), and more likely to receive mechanical ventilation (30 [94%] patients vs 7 [35%] patients), either invasively or non-invasively. Most patients had organ function damage, including 35 (67%) with ARDS, 15 (29%) with acute kidney injury, 12 (23%) with cardiac injury, 15 (29%) with liver dysfunction, and one (2%) with pneumothorax. 37 (71%) patients required mechanical ventilation. Hospital-acquired infection occurred in seven (13·5%) patients.INTERPRETATION: The mortality of critically ill patients with SARS-CoV-2 pneumonia is considerable. The survival time of the non-survivors is likely to be within 1-2 weeks after ICU admission. Older patients (>65 years) with comorbidities and ARDS are at increased risk of death. The severity of SARS-CoV-2 pneumonia poses great strain on critical care resources in hospitals, especially if they are not adequately staffed or resourced.FUNDING: None.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to describe the clinical process and outcomes of severe patients in the pneumonia caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS - CoV - 2) that began to break out in Wuhan, China in December 2019. Specifically, the researchers hope to understand the basic characteristics, treatment measures and prognosis of these severe patients, especially the mortality rate within 28 days. In addition, the study also explored which factors are associated with a higher risk of death, such as age, underlying diseases and the occurrence of Acute Respiratory Distress Syndrome (ARDS). ### Research Background - **Epidemic Background**: In December 2019, a new case of pneumonia emerged in Wuhan, China, which was later confirmed to be caused by SARS - CoV - 2. This virus quickly spread to other provinces in China and around the world. - **Research Purpose**: Since the information about severe patients infected with SARS - CoV - 2 is very limited, this study aims to fill this gap and provide detailed clinical data and outcome analysis to help medical staff better identify and manage these high - risk patients. ### Methods - **Research Design**: This is a single - center, retrospective, observational study. - **Research Subjects**: The study included 52 adult severe SARS - CoV - 2 pneumonia patients who were treated in the Intensive Care Unit (ICU) of Jinyintan Hospital in Wuhan from the end of December 2019 to January 26, 2020. - **Data Collection**: Data such as patients' baseline characteristics, symptoms, laboratory test results, comorbidities, treatment measures and clinical outcomes were collected. ### Main Findings - **Patient Characteristics**: The average age of the 52 patients was 59.7 years, of which 67% were male and 40% had chronic diseases. - **Main Outcomes**: The mortality rate within 28 days was 61.5%, and the median survival time of non - survivors was 7 days (IQR 3 - 11 days). - **Risk Factors**: Compared with survivors, non - survivors were older (64.6 years vs 51.9 years), more likely to develop ARDS (81% vs 45%), and more likely to require mechanical ventilation (94% vs 35%). ### Conclusions - **High Mortality Rate of Severe Patients**: The mortality rate of severe patients with SARS - CoV - 2 pneumonia within 28 days is quite high. - **High - Risk Groups**: Patients over 65 years old, patients with underlying diseases and patients with ARDS have a higher risk of death. - **Resource Pressure**: The severity of SARS - CoV - 2 pneumonia has put great pressure on the hospital's intensive care resources, especially in the case of insufficient medical staff and resources. Through these findings, the researchers hope to provide a scientific basis for early identification of high - risk patients and optimization of treatment for severe patients.

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study